Tempest Therapeutics, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tempest Therapeutics, Inc. stock issued during period, value, issued for services for the quarter ending 2021-06-30 was $18.00M.
- Tempest Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2019 was $20.00K.
- Tempest Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2017 was $129.00K, a 16.23% decline from fiscal 2016.
- Tempest Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2016 was $154.00K, a 6.67% decline from fiscal 2015.
- Tempest Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2015 was $165.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2021-06-30 | $18.00M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $20.00K 10-K · filed 2021-03-29 | |
| 2017-12-31 | $129.00K 10-K · filed 2018-03-15 | |
| 2016-12-31 | $154.00K 10-K · filed 2018-03-15 | |
| 2015-12-31 | $165.00K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |